ASSESSMENT OF THE LEVEL OF DAYTIME SLEEPINESS IN PATIENTS WITH ARTERIAL HYPERTENSION AGAINST POLYCYSTIC OVARIAN SYNDROME
DOI:
https://doi.org/10.11603/bmbr.2706-6290.2021.3.12569Keywords:
sleep disorders, polycystic ovary syndrome, hypertensionAbstract
Summary. There is a need for a better understanding of sleep disorders in patients with polycystic ovary syndrome (PCOS) combined with hypertension to develop effective care strategies for such patients.
The aim of the study – to assess the level of daytime sleepiness in patients with hypertension on the background of polycystic ovary syndrome.
Materials and Methods. The study included 54 women with PCOS, aged (38.4±2.3), hypertension was diagnosed in 24 patients (experimental group 1) and 20 patients with normal blood pressure (comparison group). The control group consisted of 10 healthy individuals. ESS-Epworth scale was used to screen for sleep apnea syndrome.
Results. In case of hypertension on the background of PCOS the moderate likelihood of drowsiness in the following poses and actions: sitting and reading, watching TV programs, while driving is registered a passenger in the car for 1 hour without a break, lying down, resting, in the afternoon, when circumstances allow, sitting at rest in the afternoon without drinking alcohol. These patients in study group 1 have little chance of drowsiness when they sit (without activity) in a public place, such as during a meeting or in the theater, sitting with someone talking, sitting in the car behind the wheel, stopping for a few minutes. The data obtained in patients of the experimental groups 1 and 2 probably exceed the results obtained in the control group (except for "sitting in the car behind the wheel, stopping for a few minutes" in the comparison group). The data obtained indicate an increase in the level of daytime sleepiness in women with PCOS, in combination with hypertension.
Conclusions. The results indicate an increased level of daytime sleepiness, which corresponds to moderate drowsiness, in patients with hypertension on the background of polycystic ovary syndrome, while patients with PCOS without hypertension show only mild daytime sleepiness compared to the normal range of sleepiness in healthy women.
References
Mokhlesi B, Scoccia B, Mazzone T, Sam S. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertil Steril. 2012;97(3): 786-91.
Tasali E, Van Cauter E, Ehrmann DA. Polycystic ovary syndrome and obstructive sleep apnea. Sleep Med Clin. 2008;3: 37-46.
Kumarendran B, O’Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ, Wijeyaratne CN, Coomarasamy A, Arlt W, Nirantharakumar K. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS Medicine. 2018;15(3): DOI: 10.1371/journal.pmed.1002542.
Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2013;98(12): 4565-92, DOI: 10.1210/jc.2013-2350.
Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, Lehnert H. Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine Reviews. 2012;33(5): 812-41. DOI: 10.1210/er.2012-1003.
Tock L, Carneiro G, Togeiro SM, Hachul H, Pereira AZ, Tufik S, Zanella MT. Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome. Endocr Pract. 2014;20(3): 244-51. DOI: 10.4158/EP12366.OR.
Yang HP, Kang JH, Su HY, Tzeng CR, Liu WM, Huang SY. Apnea-hypopnea index in nonobese women with polycystic ovary syndrome. Int J Gynaecol Obstet 2009;105: 226-9.
Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2010;24: 717-30.
Williams B, Mancia G, Spiering W. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33): 3021-104.
Kahal H, Kyrou I, Uthman O, Brown A, Johnson S, Wall P, Metcalfe A, Tahrani AA, Randeva HS. The association between obstructive sleep apnoea and metabolic abnormalities in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep. 2018;41: 1-12.
Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Practice and Research. Clinical Endocrinology and Metabolism. 2010;24: 717-30.
Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 2: mechanisms. Sleep. 2002;25: 499-506.
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society. 2008;5: 136-43.
Fung ML. Pathogenic roles of the carotid body inflammation in sleep apnea. Mediators of Inflammation. 2014;2014: 354279.
Behan M, Wenninger JM. Sex steroidal hormones and respiratory control. Respiratory Physiology and Neurobiology. 2008;164: 213-21.
O'Malley PM Johnston LD, Bachman JF. Alcohol use among adolescents. Alcohol Health and Research World. 1998;22: 85-93.
Lee J, Eklund EE, Lambert-Messerlian G, Palomaki GE, Butterfield K, Curran P, Bourjeily G. Serum progesterone levels in pregnant women with obstructive sleep apnea: a case control study. Journal of Women’s Health. 2017;26: 259-65. DOI: 10.1089/jwh.2016.5917
Ruchała M, Bromińska B, Cyrańska-Chyrek E, Kuźnar-Kamińska B, Kostrzewska M, Batura-Gabryel H. Obstructive sleep apnea and hormones – a novel insight. Archives of Medical Science. 2017;13: 875-84.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bulletin of Medical and Biological Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
